Frontlight ResearchEarly access
Not yet taking people in United StatesNo phase
Development of Healthcare Transition for Patients With Congenital Adrenal Hyperplasia
Key facts
- Who runs it
- University of Alabama at Birmingham
- Where
- Birmingham, United StatesSee the site
- Trial code
- Status
- Not yet recruiting
- People taking part
- 40 people, planned
- Starts
- Jan 2027
- Expected to end
- Dec 2029
- Type of study
- Observational, 3 groups
- Treatments tested
- exposure to healthcare transition protocol
- Record updated
- 14 October 2026
Who can take part
- Age
- 16 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- YA Participants
- Diagnosis of congenital adrenal hyperplasia (any subtype or severity)
- Age ≥16 years
- Active follow-up within the pediatric endocrinology clinic
- English-speaking
- Cognitively able to complete questionnaires with or without assistance
- Anticipated ability to participate in CAH-T visits during the study period Caregiver Participants
- Parent, guardian, or primary support person of an enrolled AYA participant Provider Participants
- Pediatric endocrinologists, nurse practitioners, or transition-related clinical staff involved in CAH care for at least 6 months
Who cannot take part
- Significant cognitive impairment precluding participation
- Inability to complete study procedures
- Inability to provide informed consent/assent
Where in United States
- University of Alabama at BirminghamBirmingham, United StatesContact: Christy Foster, MDNot yet recruiting
About the trial
What the trial wants to find out
The purpose of this study is to implement and evaluate the feasibility and acceptability of a structured healthcare transition program for adolescents and young adults with congenital adrenal hyperplasia (CAH). The study will also examine preliminary effects of the program on transition readiness, disease-specific self-management knowledge, emergency preparedness, continuity of endocrine care, and health-related quality of life as participants transition from pediatric to adult healthcare services.
The 3 groups in the trial
- adolescent and young adult with congenital adrenal hyperplasia
Treatment: exposure to healthcare transition protocol
- guardian/caregiver of adolescent/young adult with congenital adrenal hyperplasia
Treatment: exposure to healthcare transition protocol
- clinical provider of patients with congenital adrenal hyperplasia
Treatment: exposure to healthcare transition protocol
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Evaluation of a Healthcare Transition Protocol for Patients With Congenital Adrenal Hyperplasia
- Record updated
- 14 October 2026